नवीनतम
Glenmark acquires Acetylcysteine injection
NEW DELHI [Maha Media]: Glenmark Pharmaceuticals Ltd on Monday said it has acquired generic version of Acetylcysteine injection from Aspen Pharma USA Inc for an undisclosed sum and launched the same in the US market.
The acquisition by Glenmark Pharmaceuticals Inc. USA, an arm of the company, of Acetylcysteine Injection is of strength 6 gm/30 mL (200 mg/mL) in single-dose vials, Glenmark Pharmaceuticals said in a statement.
Glenmark acquired the ANDA for Acetylcysteine injection, 6 gm/30 ml (200 mg/ml) single-dose vials from Aspen Pharma USA Inc.
